2/7/2019 9:27:41 AM
Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) FY19 Rev. Estimate To 1738 M From 1706 M
2/7/2019 9:27:31 AM
Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) FY18 Rev. Estimate To 1492 M From 1501 M
2/7/2019 9:27:19 AM
Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q4 18 Rev. Estimate To 354.9 M From 363.8 M
2/7/2019 9:26:52 AM
Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) FY19 Estimate To 0.41 From 0.27
2/7/2019 9:26:00 AM
Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) FY18 Estimate To -0.60 From -0.63
2/7/2019 9:25:46 AM
Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) Q4 18 Estimate To -0.19 From -0.21
2/7/2019 9:25:16 AM
Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $127 Price Target
12/3/2018 2:28:46 PM
BioMarin Promotes Amy Wireman To Group VP, Human Resources
10/25/2018 4:38:51 PM
BioMarin Q3 Loss/share $0.07, Same As Last Year
10/16/2018 6:23:09 AM
Jefferies Is Lowering Biomarin Pharmaceutical Inc. (BMRN) FY20 Estimate To 0.87 From 0.94
10/16/2018 6:22:58 AM
Jefferies Is Raising Biomarin Pharmaceutical Inc. (BMRN) FY19 Estimate To 0.12 From 0.04
10/16/2018 6:22:48 AM
Jefferies Is Increasing Biomarin Pharmaceutical Inc. (BMRN) FY18 Estimate To -0.62 From -0.69
10/16/2018 6:22:00 AM
Jefferies Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY20 Rev. Estimate To 1950.2 M From 2012.0 M
10/16/2018 6:21:45 AM
Jefferies Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY19 Rev. Estimate To 1754.3 M From 1776.1 M
10/16/2018 6:21:31 AM
Jefferies Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY18 Rev. Estimate To 1513.1 M From 1513.9 M